Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. (Q45925945)
Jump to navigation
Jump to search
scientific article published on 3 July 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. |
scientific article published on 3 July 2009 |
Statements
1 reference
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. (English)
1 reference
1 reference
Andrew K Burroughs
1 reference
Spilios Manolakopoulos
1 reference
Christos Triantos
1 reference
Jiannis Theodoropoulos
1 reference
Jiannis Vlachogiannakos
1 reference
Anastasios Kougioumtzan
1 reference
Dimitrios Tzourmakliotis
1 reference
Dimitrios Karamanolis
1 reference
Athanasios Archimandritis
1 reference
Sotirios Raptis
1 reference
Alec Avgerinos
1 reference
3 July 2009
1 reference
1 reference
51
1 reference
3
1 reference
468-474
1 reference